-
1
-
-
0020550724
-
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia
-
Le Beau M.M., Larson R.A., Bitter M.A., Vardiman J.W., Golomb H.M., Rowley J.D. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. N Engl J Med 1983, 309(11):630-636.
-
(1983)
N Engl J Med
, vol.309
, Issue.11
, pp. 630-636
-
-
Le Beau, M.M.1
Larson, R.A.2
Bitter, M.A.3
Vardiman, J.W.4
Golomb, H.M.5
Rowley, J.D.6
-
2
-
-
0027373893
-
Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia
-
AUGUST (5124)
-
Liu P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M., et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 1993, 261(August (5124)):1041-1044.
-
(1993)
Science
, vol.261
, pp. 1041-1044
-
-
Liu, P.1
Tarle, S.A.2
Hajra, A.3
Claxton, D.F.4
Marlton, P.5
Freedman, M.6
-
3
-
-
0026757174
-
Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt
-
OCTOBER (7)
-
Erickson P., Gao J., Chang K.S., Look T., Whisenant E., Raimondi S., et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992, 80(October (7)):1825-1831.
-
(1992)
Blood
, vol.80
, pp. 1825-1831
-
-
Erickson, P.1
Gao, J.2
Chang, K.S.3
Look, T.4
Whisenant, E.5
Raimondi, S.6
-
4
-
-
0030658039
-
Oncogenic transcription factors in the human acute leukemias
-
NOVEMBER (5340)
-
Look A.T. Oncogenic transcription factors in the human acute leukemias. Science 1997, 278(November (5340)):1059-1064.
-
(1997)
Science
, vol.278
, pp. 1059-1064
-
-
Look, A.T.1
-
5
-
-
77955914238
-
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
-
JULY (3)
-
Grimwade D., Hills R.K., Moorman A.V., Walker H., Chatters S., Goldstone A.H., et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010, 116(July (3)):354-365.
-
(2010)
Blood
, vol.116
, pp. 354-365
-
-
Grimwade, D.1
Hills, R.K.2
Moorman, A.V.3
Walker, H.4
Chatters, S.5
Goldstone, A.H.6
-
6
-
-
0032793987
-
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
-
DECEMBER (12)
-
Byrd J.C., Dodge R.K., Carroll A., Baer M.R., Edwards C., Stamberg J., et al. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol 1999, 17(December (12)):3767-3775.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3767-3775
-
-
Byrd, J.C.1
Dodge, R.K.2
Carroll, A.3
Baer, M.R.4
Edwards, C.5
Stamberg, J.6
-
7
-
-
0038156371
-
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup
-
JULY (2)
-
Delaunay J., Vey N., Leblanc T., Fenaux P., Rigal-Huguet F., Witz F., et al. Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup. Blood 2003, 102(July (2)):462-469.
-
(2003)
Blood
, vol.102
, pp. 462-469
-
-
Delaunay, J.1
Vey, N.2
Leblanc, T.3
Fenaux, P.4
Rigal-Huguet, F.5
Witz, F.6
-
8
-
-
0028979666
-
Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group
-
SEPTEMBER (9)
-
Dastugue N., Payen C., Lafage-Pochitaloff M., Bernard P., Leroux D., Huguet-Rigal F., et al. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Leukemia 1995, 9(September (9)):1491-1498.
-
(1995)
Leukemia
, vol.9
, pp. 1491-1498
-
-
Dastugue, N.1
Payen, C.2
Lafage-Pochitaloff, M.3
Bernard, P.4
Leroux, D.5
Huguet-Rigal, F.6
-
9
-
-
33751172127
-
Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B
-
NOVEMBER (10)
-
Fröhling S., Schlenk R.F., Kayser S., Morhardt M., Benner A., Döhner K., et al. Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B. Blood 2006, 108(November (10)):3280-3288.
-
(2006)
Blood
, vol.108
, pp. 3280-3288
-
-
Fröhling, S.1
Schlenk, R.F.2
Kayser, S.3
Morhardt, M.4
Benner, A.5
Döhner, K.6
-
10
-
-
70350450588
-
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup
-
OCTOBER (28)
-
Prébet T., Boissel N., Reutenauer S., Thomas X., Delaunay J., Cahn J-Y., et al. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup. J Clin Oncol 2009, 27(October (28)):4747-4753.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4747-4753
-
-
Prébet, T.1
Boissel, N.2
Reutenauer, S.3
Thomas, X.4
Delaunay, J.5
Cahn, J.-Y.6
-
11
-
-
33344465478
-
KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival
-
MARCH (5)
-
Schnittger S., Kohl T.M., Haferlach T., Kern W., Hiddemann W., Spiekermann K., et al. KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival. Blood 2006, 107(March (5)):1791-1799.
-
(2006)
Blood
, vol.107
, pp. 1791-1799
-
-
Schnittger, S.1
Kohl, T.M.2
Haferlach, T.3
Kern, W.4
Hiddemann, W.5
Spiekermann, K.6
-
12
-
-
33748467435
-
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a cancer and leukemia group B study
-
AUGUST (24)
-
Paschka P., Marcucci G., Ruppert A.S., Mrózek K., Chen H., Kittles R.A., et al. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a cancer and leukemia group B study. J Clin Oncol 2006, 24(August (24)):3904-3911.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3904-3911
-
-
Paschka, P.1
Marcucci, G.2
Ruppert, A.S.3
Mrózek, K.4
Chen, H.5
Kittles, R.A.6
-
13
-
-
24944464648
-
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a cancer and leukemia group B study
-
AUGUST (24)
-
Marcucci G., Mrózek K., Ruppert A.S., Maharry K., Kolitz J.E., Moore J.O., et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a cancer and leukemia group B study. J Clin Oncol 2005, 23(August (24)):5705-5717.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5705-5717
-
-
Marcucci, G.1
Mrózek, K.2
Ruppert, A.S.3
Maharry, K.4
Kolitz, J.E.5
Moore, J.O.6
-
14
-
-
33748747555
-
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations
-
Appelbaum F.R., Kopecky K.J., Tallman M.S., Slovak M.L., Gundacker H.M., Kim H.T., et al. The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations. Br J Haematol 2006, 135(2):165-173.
-
(2006)
Br J Haematol
, vol.135
, Issue.2
, pp. 165-173
-
-
Appelbaum, F.R.1
Kopecky, K.J.2
Tallman, M.S.3
Slovak, M.L.4
Gundacker, H.M.5
Kim, H.T.6
-
15
-
-
84881665264
-
Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease
-
SEPTEMBER (3)
-
Hoyos M., Nomdedeu J.F., Esteve J., Duarte R., Ribera J.M., Llorente A., et al. Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease. Eur J Haematol 2013, 91(September (3)):209-218.
-
(2013)
Eur J Haematol
, vol.91
, pp. 209-218
-
-
Hoyos, M.1
Nomdedeu, J.F.2
Esteve, J.3
Duarte, R.4
Ribera, J.M.5
Llorente, A.6
-
16
-
-
84877314816
-
Therapy of core binding factor acute myeloid leukemia: incremental improvements toward better long-term results
-
APRIL (2)
-
Bhatt V.R., Kantarjian H., Cortes J.E., Ravandi F., Borthakur G. Therapy of core binding factor acute myeloid leukemia: incremental improvements toward better long-term results. Clin Lymphoma Myeloma Leuk 2013, 13(April (2)):153-158.
-
(2013)
Clin Lymphoma Myeloma Leuk
, vol.13
, pp. 153-158
-
-
Bhatt, V.R.1
Kantarjian, H.2
Cortes, J.E.3
Ravandi, F.4
Borthakur, G.5
-
17
-
-
78649905124
-
Independent prognostic variables in acute myeloid leukaemia
-
JANUARY (1)
-
Smith M.L., Hills R.K., Grimwade D. Independent prognostic variables in acute myeloid leukaemia. Blood Rev 2011, 25(January (1)):39-51.
-
(2011)
Blood Rev
, vol.25
, pp. 39-51
-
-
Smith, M.L.1
Hills, R.K.2
Grimwade, D.3
-
18
-
-
84870431609
-
Survival for older patients with acute myeloid leukemia: a population-based study
-
DECEMBER (12)
-
Oran B., Weisdorf D.J. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica 2012, 97(December (12)):1916-1924.
-
(2012)
Haematologica
, vol.97
, pp. 1916-1924
-
-
Oran, B.1
Weisdorf, D.J.2
-
19
-
-
84876551509
-
Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008
-
APRIL (15)
-
Morton L.M., Dores G.M., Tucker M.A., Kim C.J., Onel K., Gilbert E.S., et al. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood 2013, 121(April (15)):2996-3004.
-
(2013)
Blood
, vol.121
, pp. 2996-3004
-
-
Morton, L.M.1
Dores, G.M.2
Tucker, M.A.3
Kim, C.J.4
Onel, K.5
Gilbert, E.S.6
-
20
-
-
84880570189
-
Outcome of older patients with acute myeloid leukemia
-
Thein M.S., Ershler W.B., Jemal A., Yates J.W., Baer M.R. Outcome of older patients with acute myeloid leukemia. Cancer 2013, 119(15):2720-2727.
-
(2013)
Cancer
, vol.119
, Issue.15
, pp. 2720-2727
-
-
Thein, M.S.1
Ershler, W.B.2
Jemal, A.3
Yates, J.W.4
Baer, M.R.5
-
21
-
-
84855599530
-
Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
-
JANUARY (1)
-
Dores G.M., Devesa S.S., Curtis R.E., Linet M.S., Morton L.M. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood 2012, 119(January (1)):34-43.
-
(2012)
Blood
, vol.119
, pp. 34-43
-
-
Dores, G.M.1
Devesa, S.S.2
Curtis, R.E.3
Linet, M.S.4
Morton, L.M.5
-
22
-
-
84902101897
-
-
Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973-2010), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission.
-
Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973-2010), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission. http://www.seer.cancer.gov/.
-
-
-
-
23
-
-
84855792427
-
Cancer statistics, 2012
-
Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29.
-
(2012)
CA Cancer J Clin
, vol.62
, Issue.1
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
24
-
-
0003582139
-
-
World Health Organization, Geneva
-
Percy C., Fritz A., Jack A., Shanmugarathan S., Sobin L., Parkin D.M., et al. International classification of diseases for oncology (ICD-O) 2000, World Health Organization, Geneva.
-
(2000)
International classification of diseases for oncology (ICD-O)
-
-
Percy, C.1
Fritz, A.2
Jack, A.3
Shanmugarathan, S.4
Sobin, L.5
Parkin, D.M.6
-
26
-
-
84902101886
-
-
United States Department of Agriculture Economic Research Service: Rural-Urban Continuum Codes [Internet]. Available from: [cited 04.07.13].
-
United States Department of Agriculture Economic Research Service: 2003 Rural-Urban Continuum Codes [Internet]. Available from: [cited 04.07.13]. http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx.
-
(2003)
-
-
-
27
-
-
84902101887
-
-
United States Census Bureau. Census Gateway [Internet]. Available from: [cited 04.07.13].
-
United States Census Bureau. Census 2000 Gateway [Internet]. Available from: [cited 04.07.13]. http://www.census.gov/main/www/cen2000.html.
-
(2000)
-
-
-
28
-
-
79961092821
-
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
-
AUGUST (5)
-
Park J.H., Qiao B., Panageas K.S., Schymura M.J., Jurcic J.G., Rosenblat T.L., et al. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood 2011, 118(August (5)):1248-1254.
-
(2011)
Blood
, vol.118
, pp. 1248-1254
-
-
Park, J.H.1
Qiao, B.2
Panageas, K.S.3
Schymura, M.J.4
Jurcic, J.G.5
Rosenblat, T.L.6
-
29
-
-
0035469883
-
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial
-
SEPTEMBER (5)
-
Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C.J., et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001, 98(September (5)):1312-1320.
-
(2001)
Blood
, vol.98
, pp. 1312-1320
-
-
Grimwade, D.1
Walker, H.2
Harrison, G.3
Oliver, F.4
Chatters, S.5
Harrison, C.J.6
-
30
-
-
0037114753
-
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Presented in part at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001, and published in abstract form 59
-
DECEMBER (13)
-
Byrd J.C., Mrózek K., Dodge R.K., Carroll A.J., Edwards C.G., Arthur D.C., et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Presented in part at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001, and published in abstract form 59. Blood 2002, 100(December (13)):4325-4336.
-
(2002)
Blood
, vol.100
, pp. 4325-4336
-
-
Byrd, J.C.1
Mrózek, K.2
Dodge, R.K.3
Carroll, A.J.4
Edwards, C.G.5
Arthur, D.C.6
-
31
-
-
42949142189
-
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
-
Schlenk R.F., Döhner K., Krauter J., Fröhling S., Corbacioglu A., Bullinger L., et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008, 358(18):1909-1918.
-
(2008)
N Engl J Med
, vol.358
, Issue.18
, pp. 1909-1918
-
-
Schlenk, R.F.1
Döhner, K.2
Krauter, J.3
Fröhling, S.4
Corbacioglu, A.5
Bullinger, L.6
-
32
-
-
84860317991
-
Acute myeloid leukemia in the real world: why population-based registries are needed
-
APRIL (17)
-
Juliusson G., Lazarevic V.L., Hörstedt A-S., Hagberg O., Hoglund M. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood 2012, 119(April (17)):3890-3899.
-
(2012)
Blood
, vol.119
, pp. 3890-3899
-
-
Juliusson, G.1
Lazarevic, V.L.2
Hörstedt, A.-S.3
Hagberg, O.4
Hoglund, M.5
-
33
-
-
1842614240
-
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461
-
MARCH (6)
-
Byrd J.C., Ruppert A.S., Mrózek K., Carroll A.J., Edwards C.G., Arthur D.C., et al. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461. J Clin Oncol 2004, 22(March (6)):1087-1094.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1087-1094
-
-
Byrd, J.C.1
Ruppert, A.S.2
Mrózek, K.3
Carroll, A.J.4
Edwards, C.G.5
Arthur, D.C.6
-
34
-
-
79952099282
-
Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial
-
FEBRUARY (4)
-
Burnett A.K., Hills R.K., Milligan D., Kjeldsen L., Kell J., Russell N.H., et al. Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial. J Clin Oncol 2011, 29(February (4)):369-377.
-
(2011)
J Clin Oncol
, vol.29
, pp. 369-377
-
-
Burnett, A.K.1
Hills, R.K.2
Milligan, D.3
Kjeldsen, L.4
Kell, J.5
Russell, N.H.6
-
35
-
-
84902117480
-
Reasons for survival improvement in core binding factor AML: a 25 year analysis of the UK MRC/NCRI AML trials
-
NOVEMBER (21)
-
Burnett A.K., Hills R.K., Russell N., Milligan D., Hunter A.E., Clark R.E., et al. Reasons for survival improvement in core binding factor AML: a 25 year analysis of the UK MRC/NCRI AML trials. Blood 2013, 122(November (21)):358.
-
(2013)
Blood
, vol.122
, pp. 358
-
-
Burnett, A.K.1
Hills, R.K.2
Russell, N.3
Milligan, D.4
Hunter, A.E.5
Clark, R.E.6
-
36
-
-
4644288302
-
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German acute myeloid leukemia intergroup
-
SEPTEMBER (18)
-
Schlenk R.F., Benner A., Krauter J., Büchner T., Sauerland C., Ehninger G., et al. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German acute myeloid leukemia intergroup. J Clin Oncol 2004, 22(September (18)):3741-3750.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3741-3750
-
-
Schlenk, R.F.1
Benner, A.2
Krauter, J.3
Büchner, T.4
Sauerland, C.5
Ehninger, G.6
-
37
-
-
4644234164
-
The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups
-
JANUARY (9)
-
Schoch C., Kern W., Schnittger S., Buchner T., Hiddemann W., Haferlach T. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. Haematologica 2004, 89(January (9)):1082-1090.
-
(2004)
Haematologica
, vol.89
, pp. 1082-1090
-
-
Schoch, C.1
Kern, W.2
Schnittger, S.3
Buchner, T.4
Hiddemann, W.5
Haferlach, T.6
-
38
-
-
17544388046
-
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype
-
SEPTEMBER (18)
-
Bloomfield C.D., Lawrence D., Byrd J.C., Carroll A., Pettenati M.J., Tantravahi R., et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 1998, 58(September (18)):4173-4179.
-
(1998)
Cancer Res
, vol.58
, pp. 4173-4179
-
-
Bloomfield, C.D.1
Lawrence, D.2
Byrd, J.C.3
Carroll, A.4
Pettenati, M.J.5
Tantravahi, R.6
-
39
-
-
84902074946
-
Adding the KIT inhibitor dasatinib (DAS) to standard induction and consolidation therapy for newly diagnosed patients (pts) with core binding factor (CBF) acute myeloid leukemia (AML): initial results of the CALGB 10801 (alliance) study
-
NOVEMBER (21)
-
Marcucci G., Geyer S., Zhao J., Caroll A.J., Bucci D., Vij R., et al. Adding the KIT inhibitor dasatinib (DAS) to standard induction and consolidation therapy for newly diagnosed patients (pts) with core binding factor (CBF) acute myeloid leukemia (AML): initial results of the CALGB 10801 (alliance) study. Blood 2013, 122(November (21)):357.
-
(2013)
Blood
, vol.122
, pp. 357
-
-
Marcucci, G.1
Geyer, S.2
Zhao, J.3
Caroll, A.J.4
Bucci, D.5
Vij, R.6
-
40
-
-
28544447268
-
Trends in the treatment of acute myeloid leukaemia in the elderly
-
Lang K., Earle C.C., Foster T., Dixon D., Van Gool R., Menzin J. Trends in the treatment of acute myeloid leukaemia in the elderly. Drugs Aging 2005, 22(11):943-955.
-
(2005)
Drugs Aging
, vol.22
, Issue.11
, pp. 943-955
-
-
Lang, K.1
Earle, C.C.2
Foster, T.3
Dixon, D.4
Van Gool, R.5
Menzin, J.6
-
41
-
-
84896950468
-
Age and genetics how do prognostic factors at diagnosis explain disparities in acute myeloid leukemia?
-
APRIL
-
Patel M.I., Ma Y., Mitchell B.S., Rhoads K.F. Age and genetics how do prognostic factors at diagnosis explain disparities in acute myeloid leukemia?. Am J Clin Oncol 2013, (April):1.
-
(2013)
Am J Clin Oncol
, pp. 1
-
-
Patel, M.I.1
Ma, Y.2
Mitchell, B.S.3
Rhoads, K.F.4
-
42
-
-
33744487375
-
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
-
APRIL (6)
-
Boissel N., Leroy H., Brethon B., Philippe N., de Botton S., Auvrignon A., et al. Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Leukemia 2006, 20(April (6)):965-970.
-
(2006)
Leukemia
, vol.20
, pp. 965-970
-
-
Boissel, N.1
Leroy, H.2
Brethon, B.3
Philippe, N.4
de Botton, S.5
Auvrignon, A.6
-
43
-
-
84902101888
-
-
Population Characteristics Characteristics of the SEER Population Compared with the Total United States Population [Internet]. Available from: [cited 21.10.12].
-
Population Characteristics Characteristics of the SEER Population Compared with the Total United States Population [Internet]. Available from: [cited 21.10.12]. http://seer.cancer.gov/registries/characteristics.html.
-
-
-
|